Centre of Cancer Biomedicine (CCB) is a research centre that focuses on the integration of cancer related biological information from multiple science disciplines, to build a more complete picture of events and coherence. By team approach cell biologists, translational cancer scientists and computational biologists unite their efforts to elucidate the systems biology of cancer, with the ultimate goal of improving the life of cancer patients. CCB is on a daily basis run by professor Harald Stenmark, Director and professor Ragnhild Lothe, Co-director.
Centre for Immune Regulation (CIR) is a research centre located at the University of Oslo and the Rikshospitalet University Hospital. The scientific goal of the centre is to identify mechanisms of immune dysregulation that contribute to autoimmune disease and allergy. The Centre is lead by Ludvig Sollid (Director) and Inger Sandlie (Assistant Director).
Hybrid Technology Hub: The goal of the cross-disciplinary international Hybrid Technology Hub is to develop an open source “organ on a chip” platform that reproduces core functionalities of the human body and allows real time data acquisition upon exposure to therapeutic reagents. A current focus is on energy metabolism regulating organs.
K.G. Jebsen Centre for Breast Cancer Research: Vision: Towards personalized therapy for breast cancer; integrated molecular and epidemiological studies of breast cancer to reduce risk, improve prognosis, and tailor the treatment.
National Center for Neuroendocrine Tumours at the Section for Gastroenterology has been selected as a "Centre of Excellence" by the European Neuroendocrine Tumor Society (ENETS). More information about ENETS: see www.enets.org.